Role of PFKFB3 and PFKFB4 in Cancer: Genetic Basis, Impact on Disease Development/Progression, and Potential as Therapeutic Targets
Glycolysis is a crucial metabolic process in rapidly proliferating cells such as cancer cells. Phosphofructokinase-1 (PFK-1) is a key rate-limiting enzyme of glycolysis. Its efficiency is allosterically regulated by numerous substances occurring in the cytoplasm. However, the most potent regulator o...
Main Authors: | Krzysztof Kotowski, Jakub Rosik, Filip Machaj, Stanisław Supplitt, Daniel Wiczew, Karolina Jabłońska, Emilia Wiechec, Saeid Ghavami, Piotr Dzięgiel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/4/909 |
Similar Items
-
Adoptive transfer of Pfkfb3-disrupted hematopoietic cells to wild-type mice exacerbates diet-induced hepatic steatosis and inflammation
by: Xin Guo, et al.
Published: (2020-09-01) -
PFKFB3 Inhibition Impairs Erlotinib-Induced Autophagy in NSCLCs
by: Nadiia Lypova, et al.
Published: (2021-07-01) -
A Role for PFKFB3/IPFK2 in Overnutrition-Associated Adipose Tissue and Intestine Inflammatory Responses and Insulin Resistance
by: Guo, Xin
Published: (2013) -
Involvement of PFKFB3/iPFK2 in the Effects of Leucine and n-3 PUFA in Adipocytes
by: Halim, Vera
Published: (2012) -
Inhibition of Glycolysis Suppresses Cell Proliferation and Tumor Progression In Vivo: Perspectives for Chronotherapy
by: Jana Horváthová, et al.
Published: (2021-04-01)